Subscribe to RSS
DOI: 10.1055/s-0029-1217355
Trifluoromethyl-Substituted Analogues of 1-Aminocyclobutane-1-carboxylic Acid
Publication History
Publication Date:
12 June 2009 (online)
Abstract
Trifluoromethyl-substituted analogues of the 1-amino-cyclobutane-1-carboxylic acid - 1-amino-3-(trifluoromethyl) cyclobutanecarboxylic and 1-amino-3,3-bis(trifluoromethyl)cyclobutanecarboxylic acids - have been synthesized from 1,3-dibromoacetone dimethyl ketal. The key step of the syntheses is a transformation of the acid moiety into the trifluoromethyl group using SF4 and HF.
Key words
fluorine - amino acids - conformational restriction - cyclobutane - alkylation
-
1a
Tsang JW.Schmied B.Nyfeler R.Goodman M. J. Med. Chem. 1984, 27: 1663 -
1b
Gershonov E.Granoth R.Tzehoval E.Gaoni Y.Fridkin M. J. Med. Chem. 1996, 39: 4833 -
2a
Gatos M.Formaggio F.Crisma M.Toniolo C.Bonora GM.Benedetti Z.Di Blasio B.Iacovino R.Santini A.Saviano M.Kamphuis J. J. Pept. Sci. 1997, 3: 110 -
2b
Jiménez-Osés G.Corzana F.Busto JH.Pérez-Fernández M.Peregrina JM.Avenoza A. J. Org. Chem. 2006, 71: 1869 - 3
Robins LI.Dixon SM.Wilson DK.Kurth MJ. Bioorg. Med. Chem. 2006, 14: 7728 - 4
Wrobleski ML.Reichard GA.Paliwal S.Shah S.Tsui H.-C.Duffy RA.Lachowicz JE.Morgan CA.Varty GB.Shih N.-Y. Bioorg. Med. Chem. Lett. 2006, 16: 3859 - 5
Gaoni Y.Chapman AG.Parvez N.Pook PC.-K.Jane DE.Watkins JC. J. Med. Chem. 1994, 37: 4288 - 6
Allan RD.Hanrahan JR.Hambley TW.Johnston GAR.Mewett KN.Mitrovic AD. J. Med. Chem. 1990, 33: 2905 - 7
Kabalka GW.Yao M.-L. J. Org. Chem. 2004, 69: 8280 -
8a
Martarello L.McConathy J.Camp VM.Malveaux EJ.Simpson NE.Simpson CP.Olson JJ.Bowers GD.Goodman MM. J. Med. Chem. 2002, 45: 2250 -
8b
Shoup TM.Goodman MM. J. Labelled Compd. Radiopharm. 1999, 42: 215 -
8c
Goodman MM. inventors; WO 2007001940 A2 20070104. -
9a
O’Hagan D.Rzepa HS. Chem. Commun. 1997, 645 -
9b
Kirsch P. In Modern Fluoroorganic Chemistry Wiley-VCH; Weinheim: 2004. - 10
Gallucci RR.Going R. J. Org. Chem. 1981, 46: 2532 -
11a
Perkin WH. Ber. Dtsch. Chem. Ges. 1883, 16: 1787 -
11b
Perkin WH. Ber. Dtsch. Chem. Ges. 1884, 17: 54 -
11c
Pigou PE.Schiesser CH. J. Org. Chem. 1988, 53: 3841 -
12a
Bergs H. inventors; DE 566094. ; Chem. Abstr. 1933, 27: 1001 -
12b
Bucherer HR.Barsch H. J. Prakt. Chem. 1934, 140: 151 - 13
Dmowski W. Houben-Weyl Methods of Organic Chemistry Vol. E10a:Baasner B.Hagemann H.Tatlow JC. Thieme; Stuttgart: 1999. p.321
References and Notes
Spectral and Analytical
Data for New Compounds
Diisopropyl
3-Oxo-1,1-cyclobutanedicarboxylate (10)
¹H
NMR (400 MHz, CDCl3): δ = 5.10 [m, J = 6.4 Hz,
2 H, CH(CH3)2],
3.58 (s, 4 H, CH2), 1.26 [d, J = 6.4
Hz, 12 H, CH(CH
3)2]. ¹³C
NMR (100 MHz, CDCl3): δ = 200.95 (s, CH2
CO), 169.64 (s, COO), 69.66 [s, CH(CH3)2],
54.98 (s, CH2CO), 43.54 [s, C(COOi-Pr)2],
21.14 [s, CH(CH3)2].
MS: m/z = 243 [M + 1].
Diisopropyl 6,8-Dioxo-5,7-diazaspiro[3.4]octane-2,2-dicarboxylate
(11)
Mp 142-143 ˚C. ¹H
NMR (400 MHz, CDCl3): δ = 8.75
(br s, 1 H, NH), 6.69 (s, 1 H, NH), 5.03 [m, 2 H, CH(CH3)2], 3.14 (d, J = 13.6
Hz, 2 H, CH2), 2.63 (d, J = 13.6
Hz, 2 H, CH2), 1.18 [2
overlapped d, J = 6.4
Hz, 12 H, CH(CH
3)2]. ¹³C
NMR (100 MHz, CDCl3): δ = 175.70 (s,
CCONH), 172.22 (s, COO), 169.20 (s, COO),
156.08 (s, NHCONH), 70.64 [s, CH(CH3)2],
69.55 [s, CH(CH3)2],
58.16 (s, NHCCO), 46.72 (s, CH2),
41.98 [s, C(COOi-Pr)2],
39.14 (s, CH2), 21.68 [s, CH(CH3)2],
21.63 [s, CH(CH3)2].
MS: m/z = 313 [M + 1].
2,2-Bis(trifluoromethyl)-5,7-diazaspiro[3.4]octane-6,8-dione
(13)
Mp >230 ˚C. ¹H
NMR [500 MHz, (CD3)2SO]: δ = 10.88
(s, 1 H, NH), 8.59 (s, 1 H, NH), 3.14 (d, J = 12.0
Hz, 2 H, CH2), 2.69 (d, J = 12.0 Hz,
2 H, CH2). ¹9F NMR [377
MHz, (CD3)2SO]: δ = -71.72
(q, 4
J
F-F = 7.4
Hz, CF3), -73.13 (q, 4
J
F-F = 7.4
Hz, CF3). ¹³C NMR [125
MHz, (CD3)2SO]: δ = 176.23
(s, CCONH), 157.14 (s, NHCONH), 126.87
(q, ¹
J
C-F = 280.0
Hz, CF3), 125.15 (q, ¹
J
C-F = 277.5
Hz, CF3), 55.52 (s, NHCCO),
42.73 [m, C(CF3)2],
33.79 (s, CH2). MS: m/z = 277 [M + 1].
1-Amino-3,3-bis(trifluoromethyl)cyclobutanaminium
Chloride (6)
Mp >230 ˚C. ¹H
NMR [400 MHz, (CD3)2SO]: δ = 3.21
(d, J = 16.0
Hz, 2 H, CH2), 3.07 (d, J = 16.0 Hz,
2 H, CH2). ¹9F NMR [377
MHz, (CD3)2SO]: δ = -67.21
(q, 4
J
F-F = 7.4
Hz, CF3), -67.49 (q, 4
J
F-F = 7.4
Hz, CF3). ¹³C NMR [100
MHz, (CD3)2SO]: δ = 173.35
(s, COOH), 125.15 (q, ¹
J
C-F = 273.0 Hz,
CF3), 124.65 (q, ¹
J
C-F = 272.4
Hz, CF3), 53.35 (s, NHCCO), 40.39 [m, C(CF3)2],
31.81 (s, CH2). MS: m/z = 252 [M
- Cl].
cis
-2-(Trifluoromethyl)-5,7-diazaspiro[3.4]octane-6,8-dione
(16a)
Mp >230 ˚C. ¹H
NMR [400 MHz, (CD3)2SO]: δ = 10.76
(s, 1 H, NH), 8.41 (s, 1 H, NH), 3.05 (m, 1 H, CHCF3),
2.58 (pseudo t, J = 10.0
Hz, 2 H, CH2), 2.35 (pseudo
t, J = 10.0 Hz,
2 H, CH2). ¹9F NMR [377
MHz, (CD3)2SO]: δ = -72.46 (d, ³
J
H-F = 11.3
Hz, CF3). ¹³C NMR [100
MHz, (CD3)2SO]: δ = 178.26
(s, CCONH), 156.34 (s, NHCONH), 127.02
(q, ¹
J
C-F = 274.0
Hz, CF3), 56.73 (s, NHCCO),
32.46 (q,
³
J
C-F = 3.0
Hz, CH2), 28.86 (q, ²
J
C-F = 32.0
Hz, CHCF3).
MS: m/z = 209 [M + 1].
cis
-1-Carboxy-3-(trifluoromethyl)cyclobutanaminium Chloride
(7)
Mp >230 ˚C. ¹H
NMR (400 MHz, D2O): δ = 3.26 (m, 1
H, CHCF3), 2.64 (pseudo t, J = 12.8,
8.8 Hz, 2 H, CH2), 2.48 (pseudo
t, J = 10.0
Hz, 2 H, CH2). ¹9F NMR (377 MHz, D2O): δ = -76.53
(d, ³
J
H-F = 7.5
Hz, CF3). ¹³C NMR (100 MHz,
D2O): δ = 174.40 (s, COOH), 125.10
(q, ¹
J
C-F = 273.0 Hz,
CF3), 52.26 (s, NHCCO), 29.39
(q, ²
J
C-F = 32.0
Hz, CHCF3), 28.80 (q, ³
J
C-F = 3.0
Hz, CH2). MS: m/z = 184 [M -Cl].